- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Bohai Pharmaceuticals Group Inc
+ Add to WatchlistBOPH:US
0.5400 USD 0.0600 10.00%As of 20:10:00 ET on 06/19/2013.
Snapshot for Bohai Pharmaceuticals Group Inc (BOPH)
| Open: | 0.5400 | Day's Range: | 0.5400 - 0.5400 | Volume: | 1,700 |
|---|---|---|---|---|---|
| Previous Close: | 0.6000 | 52wk Range: | 0.3700 - 0.8500 | 1-Yr Rtn: | +31.71% |
Key Statistics for BOPH
| Current P/E Ratio (ttm) | 0.5934 |
|---|---|
| Estimated P/E(06/2013) | 0.6207 |
| Relative P/E vs. SPX | 0.0372 |
| Earnings Per Share (USD) (ttm) | 0.9100 |
| Est. EPS (USD) (06/2013) | 0.8700 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 9.64 |
| Shares Outstanding (M) | 17.86 |
| 30 Day Average Volume | 1,971 |
| Price/Book (mrq) | 0.0944 |
| Price/Sale (ttm) | 0.0654 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/27/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BOPH
Company Profile & Key Executives for BOPH
Bohai Pharmaceuticals Group, Inc. produces, manufactures, and distributes traditional Chinese herbal medicines, including capsules and other products, in China. The Company's medicines address common health problems such as rheumatism, rheumatoid arthritis, respiratory diseases, viral infections, gynecological diseases and cardiovascular issues.
| Hongwei QuChairman/President/CEO | Hsiao Chin "Gene"Chief Financial Officer |
| Ning TangVP:Operations | Chunhong JiangSecretary/Treasurer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BOPH News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page